The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
c15-153: Randomized phase IB/II study of enzalutamide with and without ribociclib in patients with metastatic castrate resistant, chemotherapy naïve prostate cancer that retains RB expression.
 
William Kevin Kelly
Consulting or Advisory Role - Sanofi
Research Funding - Janssen Oncology (Inst); Novartis (Inst); Sanofi (Inst)
Other Relationship - Sanofi
 
James Luke Godwin
No Relationships to Disclose
 
Jean H. Hoffman-Censits
Honoraria - Roche/Genentech; Roche/Genentech
Consulting or Advisory Role - Roche/Genentech
Research Funding - Sanofi
Travel, Accommodations, Expenses - Roche/Genentech
 
Karen E. Knudsen
Honoraria - Celgene; CellCentric
Consulting or Advisory Role - CellCentric
Research Funding - Celgene; Sanofi
 
Renee De Leeuw
No Relationships to Disclose
 
Benjamin E. Leiby
Consulting or Advisory Role - Bayer Health
 
Traci Southwell
No Relationships to Disclose
 
Christine Hubert
No Relationships to Disclose
 
David C. Smith
Research Funding - Agensys (Inst); Atterocor (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb/Medarex (Inst); Celgene (Inst); ESSA (Inst); Exelixis (Inst); Genentech (Inst); ImClone Systems (Inst); Incyte (Inst); Lilly (Inst); MedImmune (Inst); Medivation/Astellas (Inst); Millennium (Inst); Novartis (Inst); Oncogenex (Inst); OncoMed (Inst); Regeneron (Inst); Seagen (Inst); Takeda (Inst); Tekmira (Inst); Teva (Inst)
 
Gurkamal S. Chatta
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - Bristol-Myers Squibb
Travel, Accommodations, Expenses - BMS and Astra Zeneca
 
Jahan Aghalar
No Relationships to Disclose
 
Howard I. Scher
Leadership - Asterias Biotherapeutics
Consulting or Advisory Role - Astellas Pharma; Clovis Oncology; Ferring; Janssen Research & Development; Merck; Onclive; Physicans' Education Resource; Sanofi; WIRB-Copernicus Group
Research Funding - Illumina (Inst); Innocrin Pharma (Inst); Janssen (Inst)
Travel, Accommodations, Expenses - Asterias Biotherapeutics; Ferring; Onclive; Physicans' Education Resource; WIRB-Copernicus Group
 
Rohit Bose
No Relationships to Disclose
 
Karen A. Autio
No Relationships to Disclose
 
Wassim Abida
Honoraria - CARET
Consulting or Advisory Role - Clovis Oncology
Research Funding - AstraZeneca; Clovis Oncology; GlaxoSmithKline (Inst); Zenith Epigenetics
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Susan F. Slovin
Consulting or Advisory Role - Bayer